文献速递中枢神经肿瘤放疗头颈部肿瘤放疗乳腺癌放疗

《常见不良事件评价标准患者报告结局版本》(PRO-CTCAE)解剖部位特异性条目集在放射肿瘤学急性症状性毒性评估中的内容效度

Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-06-05

研究纳入接受脑、头颈、乳腺、胸部、腹部或盆腔放疗的患者,在放疗最后一周进行定性访谈并填写解剖部位特异性PRO-CTCAE症状清单,以≥20%患者认可为条目入选标准。共完成389次访谈,53个预设PRO-CTCAE症状反映了除头颈放疗的痰/黏液增多和吞咽时口/咽痛、脑放疗的眼干/刺激、男性盆腔放疗的梗阻性泌尿症状外的所有报告毒性。PRO-CTCAE作为放疗患者症状性毒性的测量工具显示出强内容效度,并据此定义了部位特异性条目集。

要点

  • PRO-CTCAE在放疗患者中显示出强内容效度,可测量症状性毒性。
  • 53个预设症状未覆盖头颈放疗的痰/黏液增多和吞咽时口/咽痛、脑放疗的眼干/刺激及男性盆腔放疗的梗阻性泌尿症状。
  • 「皮肤灼伤」和「疼痛」条目需更高特异性以充分反映放疗期间毒性。

核心结论

  • PRO-CTCAE作为放疗患者症状性毒性的测量工具显示出强内容效度。
  • 结果为定义部位特异性PRO-CTCAE条目集以评估放疗症状性毒性提供了实证支持。
  • 本研究所定义的部位特异性PRO-CTCAE条目集目前正通过电子平台在本科室部署以捕获治疗相关毒性。

研究设计与样本

  • 研究招募接受脑、头颈、乳腺、胸部、腹部或盆腔放疗的患者,在放疗最后一周进行定性访谈并完成解剖部位特异性症状清单。
  • 共完成389次访谈,包括脑放疗46例、头颈放疗69例、乳腺放疗134例、胸部放疗30例、腹部放疗27例、女性盆腔放疗36例、男性盆腔放疗47例。
  • 患者中位年龄62岁,62%为女性。
  • 条目入选标准为≥20%的患者认可。

主要发现

  • 53个预设PRO-CTCAE症状反映了所有报告的放疗诱导毒性,但除外头颈放疗患者的痰/黏液增多和吞咽时口/咽痛、脑放疗患者的眼干/刺激以及男性盆腔放疗患者的梗阻性泌尿症状。
  • PRO-CTCAE条目「皮肤灼伤」和「疼痛」需要更高特异性以充分反映放疗期间经历的毒性。
  • 定性描述的症状性毒性经内容分析汇总,未反映在PRO-CTCAE条目库中的症状性毒性被列表记录。

关键数值与推荐

  • 条目入选标准为≥20%的患者认可。
  • PRO-CTCAE条目「皮肤灼伤」和「疼痛」需更高特异性以充分反映放疗期间毒性。
  • 头颈放疗患者的痰/黏液增多和吞咽时口/咽痛、脑放疗患者的眼干/刺激以及男性盆腔放疗患者的梗阻性泌尿症状未包含在53个预设PRO-CTCAE症状中。

临床怎么用

  • 本研究所定义的部位特异性PRO-CTCAE条目集目前正通过电子平台在本科室部署以捕获治疗相关毒性。
  • PRO-CTCAE可作为放疗患者症状性毒性的测量工具,条目集按解剖部位特异性定义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To improve assessment of symptomatic toxicity in cancer clinical trials and complement clinician-based toxicity reporting, the US National Cancer Institute developed a measurement system called the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). The objective of this study was to examine the content validity of PRO-CTCAE in patients undergoing radiation therapy and to establish anatomic site-specific item sets for implementation in cancer research. METHODS AND MATERIALS: Patients receiving radiation to the brain, head and neck, breast, thorax, abdomen, or pelvis were recruited during the final week of radiation. Participants described side effects qualitatively and completed anatomic site-specific checklists indicating the presence or absence of symptomatic toxicities drawn from the PRO-CTCAE library. Items endorsed by ≥20% of participants were selected for inclusion. Symptomatic toxicities described qualitatively were content analyzed and summarized. Symptomatic toxicities not reflected in the PRO-CTCAE item library were tabulated. RESULTS: We conducted 389 interviews of patients receiving radiation to the brain (n = 46), head and neck (n = 69), breast (n = 134), thorax (n = 30), abdomen (n = 27), female pelvis (n = 36), or male pelvis (n = 47). Median age was 62 years; 62% were female. The 53 solicited PRO-CTCAE symptoms reflected all reported radiation-induced toxicities with the exception of phlegm/mucus production and mouth/throat pain with swallowing in patients receiving head and neck radiation, eye dryness/irritation in patients undergoing brain radiation, and obstructive urinary symptoms in men receiving pelvic radiation. The PRO-CTCAE items "skin burns" and "pain" require greater specificity to adequately reflect toxicities experienced during radiation. CONCLUSIONS: PRO-CTCAE demonstrates strong content validity as a measure of symptomatic toxicities in patients receiving radiation. These results provide empirical support for the definition of site-specific PRO-CTCAE item sets to assess the symptomatic toxicities of radiation therapy. The site-specific PRO-CTCAE item sets developed herein are currently being deployed in our department via an electronic platform to capture treatment-related toxicity.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Sandler KA, Mitchell SA, Basch E, et al. Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2018. PMID: 30102201. doi:10.1016/j.ijrobp.2018.04.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。